Abstract:In this research, we employed sticky ends modified‐tetrahedral framework nucleic acids (stFNAs) as a delivery system for miR29c, referred to as stFNAs‐miR29c. In previous studies, stFNAs have exhibited remarkable capabilities in terms of drug‐loading, endocytosis capacity and stability. Through the use of stFNAs‐miR29c, we effectively addressed the challenges associated with the instability of miR29c and its limited endocytosis ability. Thus, this delivery system improved the efficiency of miR29c transportation and enhanced its biological function. By activating the Wnt pathway, stFNAs‐miR29c successfully increased the expression of RUNX2 and other factors specific to osteogenesis. This process benefited to the increased deposition of mineralised nodules and optimal bone regeneration in critical‐sized bone defects. These findings have significant implications for the broader applications of stFNAs‐miR29c in long‐term tissue regeneration and reconstruction. Certain miRNAs, notably miR29c, demonstrate a remarkable capacity to regulate cellular osteogenic differentiation. However, their application in tissue regeneration is hampered by their inherent instability and susceptibility to degradation. In this study, we developed a novel miR29c delivery system utilising tetrahedral framework nucleic acids (tFNAs), aiming to enhance its stability and endocytosis capability, augment the efficacy of miR29c, foster osteogenesis in bone marrow mesenchymal stem cells (BMSCs), and significantly improve the repair of critical‐sized bone defects (CSBDs). We confirmed the successful synthesis and biocompatibility of sticky ends‐modified tFNAs (stFNAs) and miR29c‐modified stFNAs (stFNAs‐miR29c) through polyacrylamide gel electrophoresis, microscopy scanning, a cell counting kit‐8 assay and so on. The mechanism and osteogenesis effects of stFNAs‐miR29c were explored using immunofluorescence staining, western blotting, and reserve transcription quantitative real‐time polymerase chain reaction. Additionally, the impact of stFNAs‐miR29c on CSBD repair was assessed via micro‐CT and histological staining. The nano‐carrier, stFNAs‐miR29c was successfully synthesised and exhibited exemplary biocompatibility. This nano‐nucleic acid material significantly upregulated osteogenic differentiation‐related markers in BMSCs. After 2 months, stFNAs‐miR29c demonstrated significant bone regeneration and reconstruction in CSBDs. Mechanistically, stFNAs‐miR29c enhanced osteogenesis of BMSCs by upregulating the Wnt signalling pathway, contributing to improved bone tissue regeneration. The development of this novel nucleic acid nano‐carrier, stFNAs‐miR29c, presents a potential new avenue for guided bone regeneration and bone tissue engineering research.

A Bioswitchable Sirna Delivery System: RNAi Therapy Based on Tetrahedral Framework Nucleic Acids for Bone Defect Repair

Bioswitchable Delivery of microRNA by Framework Nucleic Acids: Application to Bone Regeneration

Incorporation of Osteogenic and Angiogenic Small Interfering RNAs into Chitosan Sponge for Bone Tissue Engineering.

A Delivery System Targeting Bone Formation Surfaces to Facilitate RNAi-based Anabolic Therapy

A Bioswitchable MiRNA Delivery System: Tetrahedral Framework DNA-Based miRNA Delivery System for Applications in Wound Healing

Therapeutic RNA interference targeting CKIP-1 with a cross-species sequence to stimulate bone formation

A Novel Bioswitchable miRNA Mimic Delivery System: Therapeutic Strategies Upgraded from Tetrahedral Framework Nucleic Acid System for Fibrotic Disease Treatment and Pyroptosis Pathway Inhibition

A Tetrahedral Framework DNA‐Based Bioswitchable miRNA Inhibitor Delivery System: Application to Skin Anti‐Aging

Non-coding RNA delivery for bone tissue engineering: Progress, challenges, and potential solutions

Hierarchical Assembly of Nanostructured Coating for Sirna-Based Dual Therapy of Bone Regeneration and Revascularization.

Chitosan-gelatin Hydrogel/plga Scaffold with Dual-Delivery of TGF-β1 and BMP-2 for Osteochondral Defect Repair

A Tetrahedral DNA Nanostructure-Mediated Mirna Inhibitor Delivery System: Type H Vessel-Related Bone Healing During Distraction Osteogenesis

Bone tissue engineering based on sustained release of MiR29c-modified framework nucleic acids from an injectable hydrogel

RNA-based scaffolds for bone regeneration: application and mechanisms of mRNA, miRNA and siRNA

The immunomodulatory effects of RNA-based biomaterials on bone regeneration

MicroRNA‐29c‐tetrahedral framework nucleic acids: Towards osteogenic differentiation of mesenchymal stem cells and bone regeneration in critical‐sized calvarial defects

Bone Scaffolds Loaded with Sirna-Semaphorin4d for the Treatment of Osteoporosis Related Bone Defects

The construction of a novel xenograft bovine bone scaffold, (DSS)6-liposome/CKIP-1 siRNA/calcine bone and its osteogenesis evaluation on skull defect in rats

Designing biomaterials for the delivery of RNA therapeutics to stimulate bone healing

Chitosan/siCkip-1 Biofunctionalized Titanium Implant for Improved Osseointegration in the Osteoporotic Condition

Dual-Functionalized Graphene Oxide Based Sirna Delivery System for Implant Surface Biomodification with Enhanced Osteogenesis.